ORTHOCLONE
Dead / Cancelled — Cancelled — Section 8 (as of 18 Mar 2016)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 73337989
- Registration number
- 1229215
- Mark type
- Word mark
- Filed
- 19 Nov 1981
- Published for opposition
- 14 Dec 1982
- Registered
- 08 Mar 1983
- Next maintenance due
- 08 Mar 2003
- Attorney of record
- RICHARD F. BIRIBAUER
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal Antibody Used as Therapeutic Agent in Immune Deficient Disease States
Owner
- JOHNSON & JOHNSON, NEW BRUNSWICK, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prior registrations
Prosecution history
- 18 Mar 2016 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 16 Apr 2008 — CASE FILE IN TICRS
- 13 Apr 2003 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 13 Apr 2003 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Jan 2003 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 30 Jan 2003 — PAPER RECEIVED
- 02 Jun 1989 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Mar 1989 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 08 Mar 1983 — REGISTERED-PRINCIPAL REGISTER
- 14 Dec 1982 — PUBLISHED FOR OPPOSITION
- 02 Nov 1982 — NOTICE OF PUBLICATION
- 06 Oct 1982 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Aug 1982 — NON-FINAL ACTION MAILED
- 09 Aug 1982 — ASSIGNED TO EXAMINER